SGNT

Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Results

[GlobeNewswire] – SCHAUMBURG, Ill. — Sagent Pharmaceuticals, Inc. , a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced financial results for the fourth quarter … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboardSee who Sagent is hiring next, click here to view […]

Sagent Pharmaceuticals Appoints James M. Hussey as President

[at noodls] – SCHAUMBURG, Ill., March 19, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboardSee who Sagent is hiring next, click here to view […]

Sagent Pharmaceuticals Announces Amendment to Supply Agreement With Actavis, Inc.

[at noodls] – SCHAUMBURG, Ill., March 5, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader in specialty injectable pharmaceutical products, today announced the signing of an amendment to … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboardSee who Sagent is hiring next, click here to view […]

Sagent Pharmaceuticals Announces the Approval and Launch of Zoledronic Acid Injection 4 mg in a Plastic Vial

[at noodls] – SCHAUMBURG, Ill., March 5, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the approval and launch of Zoledronic Acid Injection 4 mg, the generic form of the bisphosphonate … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboardSee who Sagent is hiring next, click here to view […]

Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Results

[at noodls] – Record Quarterly Revenue and Earnings Driven by New Product Launches Company Achieves Revised Fiscal Year 2012 Guidance SCHAUMBURG, Ill., Feb. 14, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboardSee who Sagent is hiring next, click here to view […]

Sagent Pharmaceuticals Announces the Temporary Importation of Sodium Bicarbonate Injection, USP

[at noodls] – SCHAUMBURG, Ill., Jan. 9, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that due to the current critical shortage of Sodium Bicarbonate Injection, USP in the United … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboardSee who Sagent is hiring next, click here to view […]

Sagent Pharmaceuticals to Present at 31st Annual J.P. Morgan Healthcare Conference

[at noodls] – SCHAUMBURG, Ill., Jan. 4, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboardSee who Sagent is hiring next, click here to view […]

Sagent Pharmaceuticals Announces the Launch of Flumazenil Injection, USP

[at noodls] – SCHAUMBURG, Ill., Jan. 2, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced the … moreView todays social media effects on SGNTView the latest stocks trending across Twitter. Click to view dashboardSee who Sagent is hiring next, click here to view […]